| 1 |
Howell CA, Kemppinen A, Allgar V, Dodd M, Knowles CH, McLaughlin J, Pandya P, Whorwell P, Markaryan E, Yiannakou Y. Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D). Gut 2022;71:2430-8. [PMID: 35760493 DOI: 10.1136/gutjnl-2022-327293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Zhao J, Li X, Chen X, Zheng H, Ye K, Shi Y, Xie X, Wang J, Chen M, Li Z. Common traditional Chinese medicine therapies for diarrhea-predominant irritable bowel syndrome: An overview of systematic reviews. Journal of Traditional Chinese Medical Sciences 2022;9:330-339. [DOI: 10.1016/j.jtcms.2022.06.003] [Reference Citation Analysis]
|
| 3 |
Gutierrez AM, Frazar EM, X Klaus MV, Paul P, Hilt JZ. Hydrogels and Hydrogel Nanocomposites: Enhancing Healthcare through Human and Environmental Treatment. Adv Healthc Mater 2022;11:e2101820. [PMID: 34811960 DOI: 10.1002/adhm.202101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Ravasio R, Raimondo P. Economic impact of Enterosgel® in the hospital treatment of diarrhoeal syndromes associated with different disease conditions. abtpn 2021;8:99-105. [DOI: 10.33393/ao.2021.2345] [Reference Citation Analysis]
|
| 5 |
Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-40. [PMID: 33903147 DOI: 10.1136/gutjnl-2021-324598] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 45.0] [Reference Citation Analysis]
|
| 6 |
Prosekova EA, Panov VP, Cherepanova NG, Semak AE, Belyaeva NP, Kubatbekov TS. Structural Changes in the Digestive Tract of Broilers when Introducing a Probiotic. J Biochem Technol 2021;12:70-77. [DOI: 10.51847/nahbpyya1a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Mousavi T, Nikfar S, Abdollahi M. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opin Drug Metab Toxicol 2020;16:583-604. [PMID: 32380874 DOI: 10.1080/17425255.2020.1767067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
